Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Girlich

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|May 8, 2010
Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's diseaseC Girlich, E M Jung, E Huber, et al.
Emerging Infectious Diseases|September 29, 2025
Emergence and Polyclonal Dissemination of bla<sub>NDM-7</sub>-Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021-2023Ines Rezzoug, Delphine Girlich, Aurelien Birer, et al.
Clinical Microbiology Reviews|August 1, 2025
Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemasesRémy A Bonnin, Agnès B Jousset, Aymeric Jacquemin, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical IsolatesRémy A Bonnin, Pierre Bogaerts, Delphine Girlich, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2020
Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?Cecile Emeraud, Laura Biez, Delphine Girlich, et al.
Clinical Hemorheology and Microcirculation|August 29, 2009
Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysisC Girlich, E M Jung, I Iesalnieks, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing EnterobacteralesRémy A Bonnin, Sandrine Bernabeu, Cécile Emeraud, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Characterization of BRP<sub>MBL</sub>, the Bleomycin Resistance Protein Associated with the Carbapenemase NDMLaurent Dortet, Delphine Girlich, Anne-Laure Virlouvet, et al.
Diagnostic Microbiology and Infectious Disease|November 4, 2019
Successful use of culture and enrichment for the detection of OXA-181-producing Escherichia coli from rectal swab samples falsely categorized as negative by Xpert® Carba-RDelphine Girlich, Souad Ouzani, Isabelle Langlois, et al.
Der Internist|January 17, 2014
[A 43-year-old patient with character changes, recurrent impaired consciousness and retrograde amnesia]A Mohr, A Thiel, A Hahnel, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|May 8, 2010
Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's diseaseC Girlich, E M Jung, E Huber, et al.
Emerging Infectious Diseases|September 29, 2025
Emergence and Polyclonal Dissemination of bla<sub>NDM-7</sub>-Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021-2023Ines Rezzoug, Delphine Girlich, Aurelien Birer, et al.
Clinical Microbiology Reviews|August 1, 2025
Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemasesRémy A Bonnin, Agnès B Jousset, Aymeric Jacquemin, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical IsolatesRémy A Bonnin, Pierre Bogaerts, Delphine Girlich, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2020
Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?Cecile Emeraud, Laura Biez, Delphine Girlich, et al.
Clinical Hemorheology and Microcirculation|August 29, 2009
Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysisC Girlich, E M Jung, I Iesalnieks, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing EnterobacteralesRémy A Bonnin, Sandrine Bernabeu, Cécile Emeraud, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Characterization of BRP<sub>MBL</sub>, the Bleomycin Resistance Protein Associated with the Carbapenemase NDMLaurent Dortet, Delphine Girlich, Anne-Laure Virlouvet, et al.
Diagnostic Microbiology and Infectious Disease|November 4, 2019
Successful use of culture and enrichment for the detection of OXA-181-producing Escherichia coli from rectal swab samples falsely categorized as negative by Xpert® Carba-RDelphine Girlich, Souad Ouzani, Isabelle Langlois, et al.
Der Internist|January 17, 2014
[A 43-year-old patient with character changes, recurrent impaired consciousness and retrograde amnesia]A Mohr, A Thiel, A Hahnel, et al.
Pageof 14